Intravitreal anti-vascular endothelial growth factor injection combined with panretinal photocoagulation for neovascular glaucoma in Indonesian patients with diabetes mellitus: a prospective study

BACKGROUND The aim of this study was to determine the levels of vascular endothelial growth factor (VEGF) in the aqueous humor and the effect of intravitreal anti-VEGF injection combined with panretinal photocoagulation (PRP) on the management in diabetes mellitus (DM) patients with neovascular gla...

Full description

Bibliographic Details
Main Authors: Widya Artini, Ajeng Gracia, Aria Kekalih, Virna Dwi Oktariana, Andi Arus Victor, Anna Puspitasari Bani
Format: Article
Language:English
Published: Faculty of Medicine Universitas Indonesia 2019-10-01
Series:Medical Journal of Indonesia
Subjects:
Online Access:http://mji.ui.ac.id/journal/index.php/mji/article/view/2865
id doaj-d06ef982f10a46f2b490a5960e817734
record_format Article
spelling doaj-d06ef982f10a46f2b490a5960e8177342020-11-24T23:48:47ZengFaculty of Medicine Universitas Indonesia Medical Journal of Indonesia0853-17732252-80832019-10-0128310.13181/mji.v28i3.28652865Intravitreal anti-vascular endothelial growth factor injection combined with panretinal photocoagulation for neovascular glaucoma in Indonesian patients with diabetes mellitus: a prospective studyWidya Artini0Ajeng Gracia1Aria Kekalih2Virna Dwi Oktariana3Andi Arus Victor4Anna Puspitasari Bani5Department of Ophthalmology, Faculty of Medicine, Universitas Indonesia, Jakarta, IndonesiaDepartment of Ophthalmology, Faculty of Medicine, Universitas Indonesia, Jakarta, IndonesiaDepartment of Community Medicine, Faculty of Medicine, Universitas Indonesia, Jakarta, IndonesiaDepartment of Ophthalmology, Faculty of Medicine, Universitas Indonesia, Jakarta, IndonesiaDepartment of Ophthalmology, Faculty of Medicine, Universitas Indonesia, Jakarta, IndonesiaDepartment of Ophthalmology, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia BACKGROUND The aim of this study was to determine the levels of vascular endothelial growth factor (VEGF) in the aqueous humor and the effect of intravitreal anti-VEGF injection combined with panretinal photocoagulation (PRP) on the management in diabetes mellitus (DM) patients with neovascular glaucoma (NVG).  METHODS This study was a prospective, interventional study in DM patients with NVG. Paracentesis followed by intravitreal bevacizumab (IVB) injection was performed in all eyes. The concentration of VEGF obtained from paracentesis was measured. In week-1, the intraocular pressure (IOP), sectorial iris neovascularization (NVI), and visual acuity were documented, and management was continued with PRP laser over a period of 1 week. All parameters and additional interventions performed after PRP were also recorded.  RESULTS A total of 18 eyes from 17 patients were studied. The mean (SD) level of VEGF in the aqueous humor was 3,864 (1,468) pg/ml, and the mean (SD) of initial IOP was 39 (10.2) mmHg. There was a significant reduction in IOP in week-1 after the first intervention to 24.4 (8.0) mmHg (p = 0.001); however, at 2 weeks the IOP increased to 30.4 (6.7) mmHg. NVI showed significant regression in week-1 after IVB combined with PRP laser (p < 0.05). All eyes required additional glaucoma implants (14 eyes) and cyclocryotheraphy (4 eyes).  CONCLUSIONS In the eyes of diabetes patients with NVG, VEGF levels were high. With the use of IVB, the IOP was reduced, and NVI regressed; however, due to the severe stages of disease, all eyes required glaucoma surgery. http://mji.ui.ac.id/journal/index.php/mji/article/view/2865Ahmed glaucoma valvebevacizumabintraocular pressureneovascularizationphotocoagulationvascular endothelial growth factor
collection DOAJ
language English
format Article
sources DOAJ
author Widya Artini
Ajeng Gracia
Aria Kekalih
Virna Dwi Oktariana
Andi Arus Victor
Anna Puspitasari Bani
spellingShingle Widya Artini
Ajeng Gracia
Aria Kekalih
Virna Dwi Oktariana
Andi Arus Victor
Anna Puspitasari Bani
Intravitreal anti-vascular endothelial growth factor injection combined with panretinal photocoagulation for neovascular glaucoma in Indonesian patients with diabetes mellitus: a prospective study
Medical Journal of Indonesia
Ahmed glaucoma valve
bevacizumab
intraocular pressure
neovascularization
photocoagulation
vascular endothelial growth factor
author_facet Widya Artini
Ajeng Gracia
Aria Kekalih
Virna Dwi Oktariana
Andi Arus Victor
Anna Puspitasari Bani
author_sort Widya Artini
title Intravitreal anti-vascular endothelial growth factor injection combined with panretinal photocoagulation for neovascular glaucoma in Indonesian patients with diabetes mellitus: a prospective study
title_short Intravitreal anti-vascular endothelial growth factor injection combined with panretinal photocoagulation for neovascular glaucoma in Indonesian patients with diabetes mellitus: a prospective study
title_full Intravitreal anti-vascular endothelial growth factor injection combined with panretinal photocoagulation for neovascular glaucoma in Indonesian patients with diabetes mellitus: a prospective study
title_fullStr Intravitreal anti-vascular endothelial growth factor injection combined with panretinal photocoagulation for neovascular glaucoma in Indonesian patients with diabetes mellitus: a prospective study
title_full_unstemmed Intravitreal anti-vascular endothelial growth factor injection combined with panretinal photocoagulation for neovascular glaucoma in Indonesian patients with diabetes mellitus: a prospective study
title_sort intravitreal anti-vascular endothelial growth factor injection combined with panretinal photocoagulation for neovascular glaucoma in indonesian patients with diabetes mellitus: a prospective study
publisher Faculty of Medicine Universitas Indonesia
series Medical Journal of Indonesia
issn 0853-1773
2252-8083
publishDate 2019-10-01
description BACKGROUND The aim of this study was to determine the levels of vascular endothelial growth factor (VEGF) in the aqueous humor and the effect of intravitreal anti-VEGF injection combined with panretinal photocoagulation (PRP) on the management in diabetes mellitus (DM) patients with neovascular glaucoma (NVG).  METHODS This study was a prospective, interventional study in DM patients with NVG. Paracentesis followed by intravitreal bevacizumab (IVB) injection was performed in all eyes. The concentration of VEGF obtained from paracentesis was measured. In week-1, the intraocular pressure (IOP), sectorial iris neovascularization (NVI), and visual acuity were documented, and management was continued with PRP laser over a period of 1 week. All parameters and additional interventions performed after PRP were also recorded.  RESULTS A total of 18 eyes from 17 patients were studied. The mean (SD) level of VEGF in the aqueous humor was 3,864 (1,468) pg/ml, and the mean (SD) of initial IOP was 39 (10.2) mmHg. There was a significant reduction in IOP in week-1 after the first intervention to 24.4 (8.0) mmHg (p = 0.001); however, at 2 weeks the IOP increased to 30.4 (6.7) mmHg. NVI showed significant regression in week-1 after IVB combined with PRP laser (p < 0.05). All eyes required additional glaucoma implants (14 eyes) and cyclocryotheraphy (4 eyes).  CONCLUSIONS In the eyes of diabetes patients with NVG, VEGF levels were high. With the use of IVB, the IOP was reduced, and NVI regressed; however, due to the severe stages of disease, all eyes required glaucoma surgery.
topic Ahmed glaucoma valve
bevacizumab
intraocular pressure
neovascularization
photocoagulation
vascular endothelial growth factor
url http://mji.ui.ac.id/journal/index.php/mji/article/view/2865
work_keys_str_mv AT widyaartini intravitrealantivascularendothelialgrowthfactorinjectioncombinedwithpanretinalphotocoagulationforneovascularglaucomainindonesianpatientswithdiabetesmellitusaprospectivestudy
AT ajenggracia intravitrealantivascularendothelialgrowthfactorinjectioncombinedwithpanretinalphotocoagulationforneovascularglaucomainindonesianpatientswithdiabetesmellitusaprospectivestudy
AT ariakekalih intravitrealantivascularendothelialgrowthfactorinjectioncombinedwithpanretinalphotocoagulationforneovascularglaucomainindonesianpatientswithdiabetesmellitusaprospectivestudy
AT virnadwioktariana intravitrealantivascularendothelialgrowthfactorinjectioncombinedwithpanretinalphotocoagulationforneovascularglaucomainindonesianpatientswithdiabetesmellitusaprospectivestudy
AT andiarusvictor intravitrealantivascularendothelialgrowthfactorinjectioncombinedwithpanretinalphotocoagulationforneovascularglaucomainindonesianpatientswithdiabetesmellitusaprospectivestudy
AT annapuspitasaribani intravitrealantivascularendothelialgrowthfactorinjectioncombinedwithpanretinalphotocoagulationforneovascularglaucomainindonesianpatientswithdiabetesmellitusaprospectivestudy
_version_ 1725484580482318336